RECRUITING

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer patients keep their jobs during and after treatment. The app provides advice for patients to use when having conversations about breast cancer with their employers and their doctors. The app is called TEAMWork (Talking to Employers And Medical staff about Work). In this study, the investigators are asking breast cancer patients who are about to receive treatment or who are currently receiving treatment to tell us what aspects of the app work well, so that they can learn how to improve it.

Official Title

Breast Cancer and the Workforce: Talking to Employers and Medical Staff About Work (TEAMWork)

Quick Facts

Study Start:2018-06-07
Study Completion:2026-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03572374

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Victoria Blinder, M.D., M.Sc.
CONTACT
646-888-4808
blinderv@mskcc.org
Francesca Gany, M.D., M.Sc.
CONTACT
646-888-8054

Principal Investigator

Victoria Blinder, M.D., M.Sc.
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Basking Ridge (Consent and Follow-up)
Basking Ridge, New Jersey, 07920
United States
Memorial Sloan Kettering Monmouth (Consent and Follow-up)
Middletown, New Jersey, 07748
United States
Memorial Sloan Kettering Bergen (Consent and Follow up)
Montvale, New Jersey, 07645
United States
Lincoln Medical and Mental Health Center
Bronx, New York, 10451
United States
Montefiore Medical Center
Bronx, New York, 10467
United States
Memorial Sloan Kettering Westchester (Consent and Follow-up)
Harrison, New York, 10604
United States
Queens Cancer Center of Queens Hospital
Jamaica, New York, 11432
United States
Bellevue Hospital Center (Data Collection Only)
New York, New York, 10016
United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Victoria Blinder, M.D., M.Sc., PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-06-07
Study Completion Date2026-06

Study Record Updates

Study Start Date2018-06-07
Study Completion Date2026-06

Terms related to this study

Keywords Provided by Researchers

  • Workforce
  • Employers
  • Talking to Employers and Medical Staff About Work (TEAMWork)
  • 18-217

Additional Relevant MeSH Terms

  • Breast Cancer